Genomic Testing Is Scaling Faster Than Operations Infrastructure
The precision medicine market is expanding at a pace that is outrunning the administrative infrastructure of many genomics companies. According to a 2025 report by Grand View Research, the global genomics market is projected to grow from $28.9 billion in 2024 to over $94 billion by 2032, driven by the expansion of germline testing, somatic tumor profiling, pharmacogenomics, and direct-to-consumer genetic testing programs.
As test volume scales, the administrative workflows behind each test order — patient consent collection, sample kit logistics, lab order entry, test status tracking, and result delivery coordination — become a critical operational bottleneck. A single genomics lab processing 5,000 samples per month generates thousands of administrative touchpoints that require consistent, accurate management.
Virtual assistants are being deployed by genomics companies to own this coordination layer — allowing clinical geneticists, genetic counselors, and lab directors to focus on interpretation and patient care rather than administrative follow-up.
Patient Consent Management in Genomic Testing
Informed consent in genomics is more complex than in most medical testing contexts. Genetic testing raises questions about incidental findings, data sharing, research use of samples, and family implications that require clear communication and documented consent decisions. CLIA and CAP requirements, HIPAA, and the Genetic Information Nondiscrimination Act (GINA) all create a compliance framework around how consent is obtained, documented, and maintained.
For direct-to-patient genomics programs or hospital-based germline testing services, consent management at scale requires a structured process. A virtual assistant supporting patient consent coordination can:
- Send consent form packets to patients via secure patient portal, email, or mail, tracking delivery and receipt confirmation
- Follow up with patients who have not returned signed consent forms within the defined window
- Review returned consent forms for completeness — flagging missing signatures, undated forms, or incomplete selections before sending to the clinical team
- Log consent receipt and version in the patient record management system, maintaining an audit trail
- Track consent expirations for long-term research protocols that require periodic renewal
- Coordinate consent translation requests for non-English-speaking patients under patient services guidance
Lab Order Entry and Tracking
Lab order management in a high-volume genomics environment requires accurate test code selection, insurance verification (where applicable), sample collection coordination, and order status tracking through accessioning, extraction, sequencing, and analysis stages.
Errors or delays in lab order management delay results, increase reorder rates, and frustrate clinicians and patients alike. A 2024 survey by the Association for Molecular Pathology found that order entry errors and sample tracking breakdowns accounted for 41% of clinical genomics turnaround time complaints from ordering providers.
A virtual assistant managing lab order workflows can:
- Enter test orders into the laboratory information system (LIS) from requisition forms, following test code protocols under lab manager oversight
- Verify insurance coverage and authorization for covered genetic tests, coordinating with payers when pre-authorization is required
- Coordinate sample kit dispatch to patients or collection sites, tracking shipment and receipt
- Monitor order status through each processing stage, flagging orders that have exceeded expected turnaround time benchmarks
- Manage reorder requests when samples are insufficient, rejected, or lost in transit
- Generate daily order status reports for the operations and clinical teams
Result Delivery and Post-Result Follow-Up
Genomic test results are not simple positive/negative reports. They require thoughtful delivery — particularly for germline testing where results may have implications for family members, insurance, and life planning decisions. The logistics of result delivery — which results require genetic counselor review before release, which require direct physician communication, which can be released through the patient portal — must be carefully managed.
A virtual assistant supporting result delivery operations can:
- Monitor the results queue and categorize results by delivery pathway — genetic counselor review required, direct physician notification, or standard portal release
- Schedule post-result genetic counseling appointments for patients receiving positive, variant of uncertain significance (VUS), or clinically significant findings
- Send result notification communications to ordering providers and patients according to protocol
- Track result receipt acknowledgments from ordering providers and follow up on unacknowledged reports
- Coordinate critical result escalation — immediately routing findings that require urgent clinical intervention to the responsible clinician
- Manage post-result question inboxes — triaging patient and provider questions for genetic counselor response
Scaling with Confidence
Genomics companies that have formalized VA support in their consent, order, and result coordination workflows report measurable improvements in turnaround time, order error rates, and patient satisfaction scores. The key is establishing clear standard operating procedures, access controls aligned with HIPAA requirements, and defined escalation pathways for clinical decisions.
Stealth Agents provides virtual assistants with healthcare administrative experience who can be integrated into genomics company operations teams and trained on company-specific LIS platforms, consent management processes, and result delivery protocols.
Sources
- Grand View Research, Global Genomics Market Size & Forecast Report, 2025
- Association for Molecular Pathology, Clinical Genomics Lab Operations Survey, 2024
- Genetic Information Nondiscrimination Act (GINA), 29 CFR Part 1635
- CLIA and CAP Laboratory Accreditation Standards, 2025 Update
- HIPAA Privacy Rule, 45 CFR Parts 160 and 164